🇺🇸 FDA
Patent

US 8372860

Carboline derivatives useful in the inhibition of angiogenesis

granted A61KA61K31/337A61K31/4353

Quick answer

US patent 8372860 (Carboline derivatives useful in the inhibition of angiogenesis) held by PTC THERAPEUTICS, INC. expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/337, A61K31/4353, A61K31/437, A61K31/444